[1]
李兰娟, 卢亦愚, 翁景清, 严菊英, 吴南屏, 沃健儿, 龚黎明, 朱函坪, 李敏红, 陆群英, 程苏云, 张严峻, 姚苹苹, 梅玲玲, 王志刚, 茅海燕, , , , 2004: Phylogenic Analysis of SARS-Coronavirus Isolated from Zhejiang Province, Virologica Sinica, 19, 14-17.
[2]
杨怡, 陈德蕙, 端青, 朱虹, 郎振为, 孟忻, 张德添, 张飒, 2005: Morphological Evidence of SARS Associated Reovirus, Virologica Sinica, 20, 105-107.
[3]
Ashutosh Singh, Rahul Soloman Singh, Phulen Sarma, Gitika Batra, Rupa Joshi, Hardeep Kaur, Amit Raj Sharma, Ajay Prakash, Bikash Medhi, 2020: A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV, Virologica Sinica, 35, 290-304. doi: 10.1007/s12250-020-00252-z
[4]
王瑞琳, 金宁一, 赵博, 金洪涛, 贾雷立, 金明兰, 2005: Expression of the Gene Encoding the N Protein of SARS Virus in E.coli and Its Use in the Immunization of Horses, Virologica Sinica, 20, 582-585.
[5]
姚华宁, 王战会, 韩梅芳, 侯金林, 罗小平, 宁琴, 2006: Nucleocapsid Protein of SARS-associated Coronavirus Upregulates the Transcription of hfgl2 Prothrombina -se/fibroleukin Gene, Virologica Sinica, 21, 319-323.
[6]
秦莉, 吴少庭, 王西明, 袁仕善, 黄达娜, 雷民军, 潘晖榕, 高世同, 张仁利, 屈伸, 2005: Purification of Glutathione S-transferase Fusion Proteins of SARS Coronavirus Spike Protein fragment 2 and Preparation of Anti-GST-S2 Polyclonal Antibody, Virologica Sinica, 20, 217-220.
[7]
黄嘉凌, 段朝晖, 罗小红, 吴立志, 檀卫平, 闽军, 黄健, 刘然义, 黄必军, 李焱, 曾益新, 黄文林, 2005: Predominance of Th2 Cytokine Response at Acute Phase in 95 Patients with SARS and its Clinical Significance, Virologica Sinica, 20, 341-345.
[8]
Jingchang Xue, Yaoming Li, Xiaoyi Xu, Jie Yu, Hu Yan, Huimin Yan, 2015: EV71 infection correlates with viral IgG preexisting at pharyngolaryngeal mucosa in children, Virologica Sinica, 30, 146-152. doi: 10.1007/s12250-014-3555-2
[9]
Raouia ElFihry, Mohcine Elmessaoudi-Idrissi, Fatima-Zahra Jadid, Imane Zaidane, Hajar Chihab, Mohamed Tahiri, Mostafa Kabine, Wafaa Badre, Isabelle Chemin, Agnes Marchio, Pascal Pineau, Sayeh Ezzikouri, Soumaya Benjelloun, 2020: Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients, Virologica Sinica, 35, 566-574. doi: 10.1007/s12250-020-00220-7
[10]
王汉中, 丁清泉, 2003: Severe Acute Respiratory Syndrome And Coronaviruses, Virologica Sinica, 18, 303-306.
[11]
Qingrong Zhang, Lijun Sun, Yuxuan Liang, Wenlu Zou, Jingtao Huang, Yuan Zhang, Yi Jin, Na Zhou, Jiangzhu Ye, Huachun Zou, Hao Wu, Tong Zhang, Bin Su, Taiyi Jiang, Haitao Chen, 2025: Patterns of liver fibrosis evolution in Chinese HIV/HBV co-infected adults following 5-year antiretroviral treatment: A longitudinal study using non-invasive APRI and Fib-4 scores, Virologica Sinica, 40, 118-124. doi: 10.1016/j.virs.2024.12.009
[12]
蔡恒玲, 吴移谋, 万艳平, 肖建华, 杨秋林, 曾桥, 赵飞骏, 唐曼娟, 2005: Construction of the Eukariotic Expression Vector for s1 Gene Fragment of SARS-CoV and its Immunol ogical Effects, Virologica Sinica, 20, 464-467.
[13]
Danrong Shi, Keda Chen, Xiangyun Lu, Linfang Cheng, Tianhao Weng, Fumin Liu, Nanping Wu, Lanjuan Li, Hangping Yao, 2022: Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro, Virologica Sinica, 37, 295-298. doi: 10.1016/j.virs.2022.01.031
[14]
Jian Chen, Jian Liu, Zhilu Chen, Daobin Feng, Cuisong Zhu, Jun Fan, Shuye Zhang, Xiaoyan Zhang, Jianqing Xu, 2023: Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells, Virologica Sinica, 38, 128-141. doi: 10.1016/j.virs.2022.12.002
[15]
Kangyin Li, Qi Liu, Yan Wu, Bihao Wu, Shaohong Chen, Xinghai Zhang, Xiaoying Jia, Rui Gong, Yucai Peng, Huajun Zhang, Sandra Chiu, 2024: A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1, Virologica Sinica, 39, 833-835. doi: 10.1016/j.virs.2024.08.003
[16]
Ke Wang, Yu Pan, Dianbing Wang, Ye Yuan, Min Li, Yuanyuan Chen, Lijun Bi, Xian-En Zhang, 2023: Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry, Virologica Sinica, 38, 595-605. doi: 10.1016/j.virs.2023.06.005
[17]
Lu Zhang, Siyu Tian, Jun Dai, Yuanyuan Li, Yu Zhou, Yan Li, Jiao Xu, Shuyun Liu, Zhiwei Lin, Zhaoyong Zhang, Jiantao Chen, Peilan Wei, Jingxian Zhao, Jing Jin, Yanqun Wang, Jincun Zhao, 2024: Trivalent SARS-CoV-2 virus-like particle vaccines exhibit broad-spectrum neutralization and protection against XBB.1 and BA.2.86 variants, Virologica Sinica, 39, 836-839. doi: 10.1016/j.virs.2024.08.005
[18]
江丽芳, 赵卫, 晏辉钧, 方丹云, 周经姣, 龙北国, 吴义芳, 周俊梅, 张文炳, 郭辉玉, , , 2003: Isolation and Identification of SARS．CoronaviFUS, Virologica Sinica, 18, 544-547.
[19]
陆承平, 2003: Comparison of SARS Virus and Animal Coronaviruses, Virologica Sinica, 18, 307-309.
[20]
Jiang-Fan Li, Lei He, Yong-Qiang Deng, Shu-Hui Qi, Yue-Hong Chen, Xiao-Lu Zhang, Shi-Xiong Hu, Rui-Wen Fan, Guang-Yu Zhao, Cheng-Feng Qin, 2021: Generation and Characterization of a Nanobody Against SARS-CoV, Virologica Sinica, 36, 1484-1491. doi: 10.1007/s12250-021-00436-1